Literature DB >> 21291654

Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population.

Wayne P Gulliver1, Don Macdonald, Neil Gladney, Reza Alaghehbandan, Proton Rahman, K Adam Baker.   

Abstract

BACKGROUND: Psoriasis is a common chronic immune-mediated inflammatory disorder of the skin with several associated comorbidities.
OBJECTIVE: To assess the prevalence of comorbidities in a cohort of psoriasis patients within the Canadian province of Newfoundland and Labrador (NL).
METHODS: This cross-sectional observational study investigated hospital-coded comorbidities associated with psoriasis in comparison to the general NL hospitalized population.
RESULTS: Patients died significantly younger than the general population, with patients having an earlier disease onset (≤ 25 years) dying at a younger age than those with a later onset (> 25 years; 59.3 vs 71.2; p  =  .001). Patients were hospitalized more frequently for several system disorders than the general population, and a potential association was observed between prognostic factors such as age at onset, disease severity, and HLA-Cw6 genotype and certain comorbid conditions.
CONCLUSION: This study supports an association between psoriasis and other conditions, such as circulatory and endocrine diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21291654     DOI: 10.2310/7750.2010.10013

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  6 in total

Review 1.  Genetic markers for cardiovascular disease in psoriasis: the missing piece.

Authors:  Tiago Torres; Andrea Chiricozzi; Sergio Chimenti; Rosita Saraceno
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

2.  Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveals Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists.

Authors:  Jochen H O Hoffmann; Christian Knoop; Alexander Enk; Eva N Hadaschik
Journal:  Acta Derm Venereol       Date:  2021-09-30       Impact factor: 3.875

3.  Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR).

Authors:  A B Kimball; C Leonardi; M Stahle; W Gulliver; M Chevrier; S Fakharzadeh; K Goyal; S Calabro; W Langholff; A Menter
Journal:  Br J Dermatol       Date:  2014-07-16       Impact factor: 9.302

4.  HLA-Cw6 Status and Treatment Responses Between Psoriasis Patients.

Authors:  Berkay Temel; Esra Adisen; Sevim Gonen
Journal:  Indian J Dermatol       Date:  2021 Nov-Dec       Impact factor: 1.494

5.  Real World Studies of Psoriasis and Mental Illness in Newfoundland and Labrador.

Authors:  Winifred Badaiki; Michelle Penney; Evelyn Pyper; Kendra Lester; Janelle Skeard; Janey Shin; Brenda Fisher; Susanne Gulliver; Wayne Gulliver; Proton Rahman
Journal:  J Cutan Med Surg       Date:  2022-08-07       Impact factor: 2.854

6.  Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries.

Authors:  Ole Ahlehoff; Jesper Lindhardsen; Gunnar H Gislason; Jonas B Olesen; Mette Charlot; Lone Skov; Christian Torp-Pedersen; Peter R Hansen
Journal:  BMC Cardiovasc Disord       Date:  2012-09-24       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.